Ibotta, Inc. IBTA
41.06
(0.62)
(1.49%)
as of 25 Sep
- Market cap
- $966.0M
- P/E
- 0.0×
Follow IBTA
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 189.42 | 10.55 |
+8 more quarters Free account |
P/S ratio |
2.32 | 2.13 | 1.88 | 2.21 | |
P/FCF ratio |
13.57 | 10.43 | 10.58 | 12.22 | |
P/Operating CF |
59.98 | 23.82 | 23.19 | 35.84 | |
P/B ratio |
3.29 | 2.91 | 2.24 | 2.37 | |
Price to Tangible BV |
3.29 | 2.91 | 2.24 | 2.37 | |
EV/Sales |
2.15 | 1.91 | 1.61 | 1.84 | |
EV/EBITDA |
0.00 | 2,114.93 | 72.15 | 29.93 | |
EV/Operating CF |
7.94 | 6.16 | 5.78 | 7.25 | |
EV/FCF |
12.62 | 9.39 | 9.03 | 10.17 | |
Quick Ratio |
1.65 | 1.73 | 1.90 | 2.11 | |
Current Ratio |
1.71 | 1.80 | 1.96 | 2.21 | |
Net Debt/EBITDA |
(96.53) | 20.77 | (216.24) | (61.23) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.63 | 0.61 | 0.57 | 0.60 | |
Operating CF/Net income |
(10.79) | (2.94) | (27.72) | 14.19 | |
Capex/Depreciation |
(1.53) | (2.43) | (4.46) | (8.71) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
16.95% | 17.58% | 16.09% | 16.84% | |
Selling, General and Administrative Expense of Revenue |
61.49% | 70.08% | 63.00% | 58.96% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
14.46% | 17.60% | 12.07% | 12.51% | |
Graham Net Nets |
0.15 | 0.18 | 0.26 | 0.28 | |
Graham Number |
0.00 | 0.00 | 5.23 | 26.45 | |
Earnings Yield |
(1.38%) | (1.10%) | 0.53% | 9.48% | |
Free Cash Flow Yield |
7.37% | 9.59% | 9.46% | 8.18% | |
Revenue per Share |
3.82 | 3.42 | 3.12 | 2.97 | |
Operating CF per Share |
0.57 | 1.26 | 0.98 | 0.78 | |
Capex per Share |
(0.22) | (0.29) | (0.39) | (0.40) | |
Free Cash Flow per Share |
0.35 | 0.97 | 0.59 | 0.38 | |
Cash per Share |
6.36 | 6.82 | 6.58 | 7.98 | |
Shareholders Equity per Share |
10.38 | 10.31 | 10.14 | 11.77 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
10.38 | 10.31 | 10.14 | 11.77 | |
Free Cash Flow |
8.05 | 23.31 | 16.63 | 10.59 | |
Working Capital |
152.17 | 160.08 | 200.17 | 248.93 | |
Capital Expenditures |
(5.20) | (7.06) | (11.17) | (11.16) | |
Net Current Asset Value |
121.81 | 130.06 | 169.67 | 215.64 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 47.11 | |
Capex to Sales |
0.06 | 0.09 | 0.13 | 0.13 | |
Net Profit Margin |
(1.38%) | (12.51%) | (1.13%) | 1.84% | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 56.62 | |
| Other line items | |||||
Average Receivables |
206.18 | 194.61 | 214.80 | 220.31 | |
Average Payables |
8.95 | 9.27 | 9.00 | 11.78 | |
Average Assets |
543.09 | 559.59 | 602.17 | 583.85 | |
Average Common Equity |
297.85 | 325.13 | 372.47 | 353.78 |
Columns are period end dates